Influence of the temperature of extracellular solutions on the evaluation of drugs that suppress hERG potassium currents (CIRCULATORY SYSTEM) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
スポンサーリンク
概要
- 論文の詳細を見る
- 日本トキシコロジー学会の論文
- 2003-10-31
著者
-
Morita Yoshiaki
Pharmacological Research Laboratories Drug Safety Testing Center Co. Ltd.
-
TSURUBUCHI Yuji
Pharmacological Research Laboratories, Drug Safety Testing Center Co., Ltd.
-
YONEZAWA Keiko
Drug Safety Testing Center Co. Ltd.
-
TSURUBUCHI Yuji
Drug Safety Testing Center Co. Ltd.
-
NEGISHI Yasunori
Drug Safety Testing Center Co. Ltd.
-
YONEZAWA KEIKO
Pharmacological Research Laboratories, Drug Safety Testing Center Co., Ltd.
-
AMAGAI MARIKO
Pharmacological Research Laboratories, Drug Safety Testing Center Co., Ltd.
-
NEGISHI YASUNORI
Pharmacological Research Laboratories, Drug Safety Testing Center Co., Ltd.
-
Tsurubuchi Yuji
Pharmacological Research Laboratories Drug Safety Testing Center Co. Ltd.
-
Amagai Mariko
Pharmacological Research Laboratories Drug Safety Testing Center Co. Ltd.
関連論文
- QT PRODACT : Evaluation of the Potential of Compounds to Cause QT Interval Prolongation by Action Potential Assays Using Guinea-Pig Papillary Muscles
- QT PRODACT : A Multi-site Study of In Vitro Action Potential Assays on 21 Compounds in Isolated Guinea-Pig Papillary Muscles
- P8-04 Optimization of the hERG assay using an automated patch-clamp system(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P6-10 False-positive and -negative effects in in vitro assays for predicting QT prolongation effects of drugs(LIVER AND DIGESTIVE SYSTEM/CIRCULATORY SYSTEM-1/DEVELOPMENT AND REPRODUCTION)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Ann
- Influence of the temperature of extracellular solutions on the evaluation of drugs that suppress hERG potassium currents (CIRCULATORY SYSTEM) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- W4-1 hERG screening assay and the reproducibility of test data(WORKSHOP 4: QT DATABASE CONSTRUCTION TO SUPPORT TO DEVELOP ICH-S7B GUIDELINE(SAFETY PHARMACOLOGY STUDIES TO EVALUATE QT INTERVAL PROLONGATION))(Proceedings of the 31st Annual Meeting)